Updated September 2026Promotional rate, listed rate higherEmbody review
Two different monthly figures sit on this seller's own pages, and which one applies depends on a promotion.
The verdict
Embody shows $79 a month for compounded semaglutide and $129 for compounded tirzepatide, both reached through a promotion applied automatically at checkout, and its terms of service list $199 a month. The two figures are the seller's own.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection · Oral
- States
- 50
- Injection
- From $79/mo
- Oral
- From $229/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Embody sells compounded semaglutide and compounded tirzepatide by injection, and also sells both as oral preparations, which puts four separate prices on one seller. The injectable semaglutide showed at $79 a month against a struck-through $299, and the injectable tirzepatide at $129 against $349. The oral versions are priced well above either, at $229 for semaglutide and $329 for tirzepatide.
Who writes the prescription, and what do they see?
A prescription is required for all four products, and the checkout is the part of this seller a reader meets first, which is the wrong way round for a decision that ends in a controlled medicine arriving by post. The pages priced here describe the product, the promotion and the bundle rungs in detail, and they describe the clinician relationship far more briefly than any of those. What the intake asks, and who reads the answers before a prescription is written, is not something the priced row establishes.
The service ships to all fifty states and arranges treatment remotely, which is unremarkable, and the interesting part is what happens to the price over a year rather than in the first week. Bundles pull the injectable semaglutide down through $76 and $73 to $69 on a twelve-month purchase, and the tirzepatide through $126 and $123 to $119. Whether the dose changes the figure is not something the seller publishes, so a reader on a rising dose should read the checkout total rather than the tile.
What happens when the dose goes up?
Whether the figure moves as the dose climbs is the question its own pages do not settle, because the seller publishes bundle rungs and a promotional rate rather than a per-dose ladder. A reader who starts at a low dose in month one and reaches a maintenance dose by month four should read the checkout total at each refill rather than the tile that sold them the first one. The oral preparations are the harder case: sublingual and injected milligrams are not interchangeable, so a dose step on the oral route is not the same event as a dose step on the injection.
What the price includes
A reader landing on the checkout sees $79, and a reader who opens the terms of service sees $199, and both documents belong to the same seller. The gap matters because the low figure is described as a promotional rate applied for you rather than a list price, and a promotion is a thing a company sets and can reset. Twelve months at $79 is $948 and twelve months at $199 is $2,388, so the question of which number governs a renewal is not a small one. What the terms say about changing the rate is worth reading before the first charge, not after it.
What it claims, and what it cites
All four products are compounded, meaning a pharmacy prepares them and no regulator reviews the finished vial or tablet before it is shipped. The oral preparations are the newer offering here and the price step from injection to oral is substantial, at $150 a month on semaglutide. A reader should know that the published trial evidence for oral semaglutide was generated with an approved tablet at label doses, and a compounded oral preparation was not what was studied.
Where it holds up, and where it does not
- Strength: Four products priced on one page
- Strength: Bundle rungs published for each product
- Strength: Ships to all fifty states
- Limitation: Terms list a rate of $199 a month
- Limitation: Low rate depends on an applied promotion
- Limitation: Oral preparations cost far more than injections
What the evidence says about this kind of treatment
The assessment above is about Embody. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader willing to read the terms of service before the checkout total, because the promotional rate and the listed rate are different numbers on the same site.
- Wrong for
- A reader who needs the first month's figure to be the figure for every month after it, since the low rate here rests on a promotion rather than on a published list price.
How Embody compares
| Seller | Who it suits | Go |
|---|---|---|
| Lean Meds | A reader deciding between paying month to month and committing a year up front, because both rungs are published side by side. | See Lean Meds → |
| Collective | A reader who will stay on treatment for a full twelve months, which is the term the annual membership is priced against. | See Collective → |
 Maximus | A reader weighing a compounded preparation against the manufacturer's own pen, where the semaglutide decision costs nothing either way. | See Maximus → |
More GLP-1 telehealth sellers reviews: BioGlow HealthDoctorAdamEnhance MDEverSlimFidelity Medical ClinicHarper Meds
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- Which price does Embody actually charge?
- The checkout showed $79 a month for injectable semaglutide at the price checked here, and the terms of service list $199. Both come from Embody, and the lower one is described as a promotion applied automatically rather than as the list price.
- Is the oral version cheaper than the injection?
- It is considerably dearer here. Oral semaglutide is $229 a month against $79 for the injection, and oral tirzepatide is $329 against $129, so the oral route costs more rather than less at this seller.
- Do the bundles change the rate per month?
- They do, on every product. Injectable semaglutide falls from $79 to $76, $73 and $69 as three, six and twelve months are bought at once, and the tirzepatide moves through $126 and $123 to $119 on the same terms.
- Is Embody expensive compared with other GLP-1 telehealth sellers?
- Embody publishes a starting figure of $79/mo. Across the 32 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $299 with a median of $139, which puts Embody below the median, toward the cheaper end. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.